Corcept Therapeutics
CORT
#2106
Rank
NZ$16.61 B
Marketcap
NZ$154.79
Share price
3.03%
Change (1 day)
28.08%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2026 (TTM): NZ$0.75

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.80. In 2025 the company made an earnings per share (EPS) of NZ$1.67 a decrease over its 2024 EPS that were of NZ$2.39.

EPS history for Corcept Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.75-55.27%
2025NZ$1.67-30.37%
2024NZ$2.39
2022NZ$1.68-2.06%
2021NZ$1.725.43%
2020NZ$1.6310.84%
2019NZ$1.4727.69%
2018NZ$1.15-42.48%
2017NZ$2.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.49 1,841.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.44 1,460.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.32 191.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$50.03 6,172.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.31 690.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.31 691.11%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$0.03545-95.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.89-211.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.48 211.11%๐Ÿ‡บ๐Ÿ‡ธ USA